AKAnna A. Kosova

Anna A. Kosova

*This is an algorithmically generated author record based on publicly available information.

Anna A. Kosova has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Modern Possibilities of Usage Dupilumab in Children

    by Anna A. Kosova, Anastasiya V. Fayans, Aishan Е. Ibaduiiaeva, Kirill S. Gusev, Anastaiya N. Nikovaeva, Dayana G. Bayburdyan, Dmitriy V. Kaiinin, Eieonora Yu. Ivanova, Marina I. Korniiova, Saak G. Serobyan, et al.

    Dupilumab is a genetically engineered immunobiological drug that has been increasingly used in recent years to treat bronchial asthma (BA), atopic dermatitis (AD) and eosinophilic esophagitis (EE) in children. The aim of the study is to analyze current literature data on the use of dupilumab in the treatment of BA, AD and EE in children. Despite the short history of dupilumab use in the pediatric population, its usage has shown promising results in the treatment of many conditions whose pathogenesis is T2 inflammation, primarily BA, AD and EE. It has demonstrated efficacy in patients with various clinical manifestations characterized by moderate to severe course or refractory to treatment, and has led to an improvement in the quality of life of patients. With the expansion of the use of dupilumab, there is more and more evidence of its usefulness in the treatment of other T-cell-mediated diseases.